Crowdfunding campaign successful
On Sunday May 13th, the ImmunoLogik team around the CEO Dr. Christian Setz and the scientific advisor Prof. Dr. Ulrich Schubert successfully finsihed their crowdinvesting campaign on aescuvest.
More than 200 investors decided to invest together over 300.000 € in the innovative development of the lead candidate IML-106 for the efficient and essential treatment of patients who have exploited all available means of the modern therapy, and who would die due to the unavoidable outbreak of AIDS.
Learn more at www.aescuvest.de/immunologik
The ImmunoLogik team expresses its gratitude and thanks all supporters.
Image source: © mohamed_hassan – pixabay.com
Comments are closed.